Doctor profile · Federal record
Dr. Sami Abbasi, DO
Dermatology Physician (CMS: Dermatology) · Woodhaven, MI
- NPI 1083778690
- Accepts Medicare
- MIPS 100.0 / 100 · 2023
- 25 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
21401 Allen RD
Woodhaven, MI 481831665
(734) 675-0835
fax (734) 675-0873
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- January 14, 2025
- Year of graduation
- 2001 — 25 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- Michigan #5101014894
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083778690. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
4,065
Distinct HCPCS
10
Medicare allowed
$308,777
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 1,236 | 210 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 617 | 467 | $91 | |
17000 |
Destruction of precancer skin growth, 1 growth | 420 | 272 | $54 | |
17110 |
Destruction of skin growth, 1-14 growths | 332 | 242 | $115 | |
11102 |
Biopsy of related skin growth, first growth | 261 | 221 | $94 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 247 | 190 | $131 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 217 | 184 | $58 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 163 | 163 | $115 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 90 | 54 | $1 | |
99202 |
New patient office or other outpatient visit, 15-29 minutes | 82 | 82 | $74 |
In context: peer comparison
Among 1 peers in Woodhaven Dermatology Physician, average services per provider: 162. This provider delivers 25× the peer median.Open Payments
Industry payments received
All-time total
$3,598
Transactions
163
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Lumenis Be INC | 1 | $541.01 | |
| Abbvie INC. | 32 | $539.20 | |
| Sun Pharmaceutical Industries INC. | 17 | $395.96 | |
| Amgen INC. | 16 | $373.79 | |
| E.R. Squibb & Sons, L.L.C. | 15 | $308.27 | |
| Janssen Biotech, INC. | 23 | $221.35 | |
| Dermavant Sciences, INC. | 21 | $202.09 | |
| Incyte Corporation | 7 | $194.22 | |
| Ucb, INC. | 8 | $154.14 | |
| Lilly USA, LLC | 6 | $121.69 | |
| Arcutis Biotherapeutics, INC. | 6 | $107.17 | |
| Pfizer INC. | 5 | $101.57 | |
| Sanofi-Aventis U.S. LLC | 1 | $99.99 | |
| Galderma Laboratories, L.P. | 3 | $48.07 | |
| Verrica Pharmaceuticals INC. | 2 | $38.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,118
Patients
739
Total drug cost
$571,045
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 207 | 166 | $2,828 |
| Ciclopirox | Generic | 151 | 98 | $6,353 |
| Doxycycline Hyclate | Generic | 125 | 51 | $3,297 |
| Ketoconazole | Generic | 110 | 68 | $2,774 |
| Clobetasol Propionate | Generic | 100 | 76 | $4,186 |
| Ammonium Lactate | Generic | 98 | 80 | $2,035 |
| Hydrocortisone | Generic | 78 | 64 | $973 |
| Humira(Cf) Pen (Adalimumab) | Brand | 50 | 0 | $541,266 |
| Metronidazole | Generic | 44 | 32 | $2,498 |
| Imiquimod | Generic | 43 | 22 | $1,605 |
Hospital affiliations
Frequently asked questions
What is Dr. Sami Abbasi's medical specialty?
Dr. Sami Abbasi practices Dermatology Physician in Woodhaven, MI.
Where does Dr. Sami Abbasi practice?
Dr. Sami Abbasi practices at 21401 Allen RD, Woodhaven, MI 481831665. Office phone: 7346750835.
What is Dr. Sami Abbasi's NPI?
Dr. Sami Abbasi's National Provider Identifier (NPI) is 1083778690, issued by NPPES.
Does Dr. Sami Abbasi accept Medicare assignment?
Yes. Dr. Sami Abbasi accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Sami Abbasi commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 1 growth (HCPCS 17000). Source: CMS Medicare Physician & Other Practitioners file.